Jullian G. Jones - Dec 1, 2021 Form 3 Insider Report for Monte Rosa Therapeutics, Inc. (GLUE)

Role
Chief Business Officer
Signature
/s/ Jullian G. Jones
Stock symbol
GLUE
Transactions as of
Dec 1, 2021
Transactions value $
$0
Form type
3
Date filed
12/2/2021, 05:12 PM
Next filing
Mar 2, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding GLUE Stock Option Grant (Right to Buy) Dec 1, 2021 Common Stock 187K $2.19 Direct F1
holding GLUE Stock Option Grant (Right to Buy) Dec 1, 2021 Common Stock 64.4K $6.14 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of this option shall vest and become exercisable on August 31, 2021, with the remainder vesting in 36 substantially equal monthly installments thereafter.
F2 25% of this option shall vest and become exercisable on April 9, 2022, with the remainder vesting in 36 substantially equal monthly installments thereafter.

Remarks:

Exhibit 24 - Power of Attorney No securities are beneficially owned.